Fresh Equities
RHINOMED LIMITED

RHINOMED LIMITED

ASX:RNO

Last Placement
Bidding Closed
Offer Price
$0.2100
Discount to Close
16.00%
Raised
$5M
Last Close
$0.2500
Market Cap at Close
Not Available
Relisted
Nov 1, 2018

Company Information

Rhinomed Limited (RNO, formerly Consegna Group Limited) is a nasal and respiratory medical technology company based in Melbourne,Australia; including (i) sport & exercise, (ii) wellbeing (appetite & anxiety), (iii) sleep/snoring & sleep apnea, and (iv) drug delivery (migraine & allergies) market. Former Names Helicon Group Limited (HCG), 28/10/2011; Consegna Group Limited (CGP), 15/11/2013

Type

Listed Company

GICS Sub-Industry

Pharmaceuticals

Head Office

97 Green St, Cremorne VIC 3121, Australia

Pharmaceuticals
Health Care

Quarterly Cash Flows

The numbers below are derived from quarterly cash flow reports provided by the company. Fresh Equities does not guarantee that the information provided is accurate, you can read the associated report by clicking read more for the quarter. Always do your own research and do not rely on the information provided here as your only source of research.



Fresh Equities

Copyright © 2018 Fresh Equities. All rights reserved.

ACN 619 657 028. CAR: 001267539 of AFSL: 471379.
Archive
Support
This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by Fresh Equities Pty Ltd, its representatives or any other third party regardless of whether such security, product or service is referenced on this website.